Related Experiment Video
Updated: Mar 1, 2026
10:56
A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes
Published on: September 15, 2018
8.6K
[Familial hypercholesterolemia: A largely underestimated cardiovascular risk]
J Ferrières1, É Bruckert2, S Béliard3
1Fédération de cardiologie, CHU Rangueil, TSA 50032, 31059 Toulouse cedex 9, France.
Annales De Cardiologie Et D'Angeiologie
|June 4, 2017
Summary
Physicians in France show significant gaps in knowledge regarding familial hypercholesterolemia (FH). This lack of understanding likely leads to underdiagnosis and inadequate management of this serious genetic lipid disorder.
Area of Science:
- Cardiology
- Genetics
- Public Health
Background:
- Familial hypercholesterolemia (FH) is an autosomal dominant genetic disorder causing high LDL cholesterol.
- Heterozygous FH affects 1/250 to 1/500 individuals, significantly increasing premature coronary artery disease risk.
- Untreated FH elevates cardiovascular risk by 13-fold compared to the general population.
Purpose of the Study:
- To assess French physicians' knowledge of heterozygous familial hypercholesterolemia (HeFH).
- To identify gaps in understanding and management of HeFH among healthcare professionals.
Main Methods:
- A survey of 495 physicians (cardiologists, endocrinologists, GPs) in France.
- Data collection via phone and internet, including 579 patient records.
Main Results:
- Only 32% of physicians could differentiate FH from polygenic hypercholesterolemia.
- Key diagnostic signs like tendinous xanthomas were noted by only 44% of cardiologists.
- Significant deficits in knowledge regarding prevalence (6%), transmission (59%), and cardiovascular risk (18%) were observed, with 57% admitting misinformation and 83% desiring more education.
Conclusions:
- Inadequate physician knowledge of HeFH contributes to diagnostic delays and suboptimal patient care.
- Targeted education is crucial to improve FH diagnosis and management in France.
Keywords:
Cardiovascular riskCascade screeningDépistage en cascadeFamilial heterozygous hypercholesterolemiaFranceHypercholestérolémie familiale hétérozygoteLDLLDL-CPrevalencePrévalenceRisque cardiovasculaireMore Related Videos
Related Concept Videos
01:29Cholesterol: Significance and Regulation
1.7K
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
1.7K
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
1.6K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.6K
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
574
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
574
01:30Coronary Artery Disease I: Introduction
1.3K
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.3K
01:26Coronary Artery Disease II: Pathophysiology
817
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
817
01:26Atherosclerosis III: Management
520
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
520